China Cord Blood Corporation announced that it has successfully completed $50 million convertible note financing with Golden Meditech Holdings Limited. The company's board has appointed Mr. Yuen Kam, currently the Chairman and Chief Executive Officer of Golden Meditech, as its director and Chairman, effective from October 3, 2012. Ms. Ting Zheng will continue her role as a member of the company's board and Chief Executive Officer of the company.